vs

Side-by-side financial comparison of AMERICAN BATTERY TECHNOLOGY Co (ABAT) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.

Prelude Therapeutics Inc is the larger business by last-quarter revenue ($6.5M vs $4.8M, roughly 1.4× AMERICAN BATTERY TECHNOLOGY Co). AMERICAN BATTERY TECHNOLOGY Co runs the higher net margin — -195.0% vs -303.5%, a 108.5% gap on every dollar of revenue. On growth, AMERICAN BATTERY TECHNOLOGY Co posted the faster year-over-year revenue change (1331.8% vs 116.7%).

American Battery Technology Company, formerly American Battery Metals Corporation, is a US-based battery recycling technology startup founded in 2011. It employs a hydrometallurgical process to recycle batteries and a targeted extraction system to extract raw materials from primary resources.

ABAT vs PRLD — Head-to-Head

Bigger by revenue
PRLD
PRLD
1.4× larger
PRLD
$6.5M
$4.8M
ABAT
Growing faster (revenue YoY)
ABAT
ABAT
+1215.1% gap
ABAT
1331.8%
116.7%
PRLD
Higher net margin
ABAT
ABAT
108.5% more per $
ABAT
-195.0%
-303.5%
PRLD

Income Statement — Q2 FY2026 vs Q3 FY2025

Metric
ABAT
ABAT
PRLD
PRLD
Revenue
$4.8M
$6.5M
Net Profit
$-9.3M
$-19.7M
Gross Margin
-33.6%
Operating Margin
-207.5%
-314.1%
Net Margin
-195.0%
-303.5%
Revenue YoY
1331.8%
116.7%
Net Profit YoY
30.7%
38.9%
EPS (diluted)
$-0.07
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABAT
ABAT
PRLD
PRLD
Q4 25
$4.8M
Q3 25
$937.6K
$6.5M
Q2 25
$2.8M
Q1 25
$980.0K
Q3 24
$3.0M
Net Profit
ABAT
ABAT
PRLD
PRLD
Q4 25
$-9.3M
Q3 25
$-10.3M
$-19.7M
Q2 25
$-10.2M
Q1 25
$-11.5M
Q3 24
$-32.3M
Gross Margin
ABAT
ABAT
PRLD
PRLD
Q4 25
-33.6%
Q3 25
-375.1%
Q2 25
-92.6%
Q1 25
-274.5%
Q3 24
Operating Margin
ABAT
ABAT
PRLD
PRLD
Q4 25
-207.5%
Q3 25
-1080.8%
-314.1%
Q2 25
-280.1%
Q1 25
-1086.3%
Q3 24
-1145.9%
Net Margin
ABAT
ABAT
PRLD
PRLD
Q4 25
-195.0%
Q3 25
-1098.5%
-303.5%
Q2 25
-366.4%
Q1 25
-1173.1%
Q3 24
-1075.7%
EPS (diluted)
ABAT
ABAT
PRLD
PRLD
Q4 25
$-0.07
Q3 25
$-0.09
$-0.26
Q2 25
$-0.09
Q1 25
$-0.14
Q3 24
$-0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABAT
ABAT
PRLD
PRLD
Cash + ST InvestmentsLiquidity on hand
$47.9M
$55.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$119.0M
$58.5M
Total Assets
$123.3M
$94.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABAT
ABAT
PRLD
PRLD
Q4 25
$47.9M
Q3 25
$30.9M
$55.0M
Q2 25
$7.5M
Q1 25
$7.8M
Q3 24
$153.6M
Stockholders' Equity
ABAT
ABAT
PRLD
PRLD
Q4 25
$119.0M
Q3 25
$96.0M
$58.5M
Q2 25
$70.6M
Q1 25
$65.6M
Q3 24
$156.4M
Total Assets
ABAT
ABAT
PRLD
PRLD
Q4 25
$123.3M
Q3 25
$101.5M
$94.8M
Q2 25
$84.5M
Q1 25
$76.5M
Q3 24
$197.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABAT
ABAT
PRLD
PRLD
Operating Cash FlowLast quarter
$-9.8M
$-19.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABAT
ABAT
PRLD
PRLD
Q4 25
$-9.8M
Q3 25
$-7.1M
$-19.1M
Q2 25
Q1 25
$-10.3M
Q3 24
$-27.3M
Free Cash Flow
ABAT
ABAT
PRLD
PRLD
Q4 25
Q3 25
Q2 25
Q1 25
Q3 24
$-27.4M
FCF Margin
ABAT
ABAT
PRLD
PRLD
Q4 25
Q3 25
Q2 25
Q1 25
Q3 24
-912.0%
Capex Intensity
ABAT
ABAT
PRLD
PRLD
Q4 25
Q3 25
0.0%
Q2 25
Q1 25
Q3 24
2.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons